Cargando…

Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents

BACKGROUND: Endoscopic submucosal dissection (ESD) has become widely accepted as a standard treatment for gastric epithelial neoplasms. Antithrombotic agents are widely used to prevent thromboembolic disease. However, the feasibility of endoscopic procedures for patients using such agents has been r...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumura, Tomoaki, Arai, Makoto, Maruoka, Daisuke, Okimoto, Kenichiro, Minemura, Shoko, Ishigami, Hideaki, Saito, Keiko, Nakagawa, Tomoo, Katsuno, Tatsuro, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287424/
https://www.ncbi.nlm.nih.gov/pubmed/25280756
http://dx.doi.org/10.1186/1471-230X-14-172
_version_ 1782351782833291264
author Matsumura, Tomoaki
Arai, Makoto
Maruoka, Daisuke
Okimoto, Kenichiro
Minemura, Shoko
Ishigami, Hideaki
Saito, Keiko
Nakagawa, Tomoo
Katsuno, Tatsuro
Yokosuka, Osamu
author_facet Matsumura, Tomoaki
Arai, Makoto
Maruoka, Daisuke
Okimoto, Kenichiro
Minemura, Shoko
Ishigami, Hideaki
Saito, Keiko
Nakagawa, Tomoo
Katsuno, Tatsuro
Yokosuka, Osamu
author_sort Matsumura, Tomoaki
collection PubMed
description BACKGROUND: Endoscopic submucosal dissection (ESD) has become widely accepted as a standard treatment for gastric epithelial neoplasms. Antithrombotic agents are widely used to prevent thromboembolic disease. However, the feasibility of endoscopic procedures for patients using such agents has been rarely investigated. The aim of this study was to identify risk factors for post-operative bleeding after gastric ESD and to evaluate the relationship between the use of antithrombotic agents and post-operative bleeding. METHODS: From June 2005 to March 2014, 413 patients with 425 gastric neoplasms were treated by ESD. The demographic and clinical parameters associated with post-operative bleeding were investigated. 83 patients receiving antithrombotic agents were separately assessed using various methods of administration during the ESD procedure. Post-operative bleeding that occurred within 5 days of ESD was defined as early post-operative bleeding, whereas subsequent bleeding was defined as delayed bleeding. RESULTS: The overall post-operative bleeding rate was 4.7%. In patients with continued low-dose aspirin (LDA), heparin replacement (HR), or continued LDA along with HR, post-operative bleeding rates were 9.5%, 23.8%, and 25.0%, respectively. On multivariate analysis, a specimen size of ≥40 mm was a risk factor for early post-operative bleeding [odds ratio (OR) 6.08, 95% CI: 1.74–21.27], and HR and chronic kidney disease (CKD) requiring hemodialysis were risk factors for delayed bleeding (OR 12.23, 95% CI: 2.63–56.77 and OR 28.35, 95% CI: 4.67–172.11, respectively). Continued LDA was not a risk factor for post-operative bleeding. CONCLUSIONS: Large specimen size is a risk factor for early post-operative bleeding, and HR and CKD requiring hemodialysis are risk factors for delayed bleeding. Patients with risk factors should be carefully watched, allowing for the timing of post-operative bleeding after ESD.
format Online
Article
Text
id pubmed-4287424
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42874242015-01-09 Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents Matsumura, Tomoaki Arai, Makoto Maruoka, Daisuke Okimoto, Kenichiro Minemura, Shoko Ishigami, Hideaki Saito, Keiko Nakagawa, Tomoo Katsuno, Tatsuro Yokosuka, Osamu BMC Gastroenterol Research Article BACKGROUND: Endoscopic submucosal dissection (ESD) has become widely accepted as a standard treatment for gastric epithelial neoplasms. Antithrombotic agents are widely used to prevent thromboembolic disease. However, the feasibility of endoscopic procedures for patients using such agents has been rarely investigated. The aim of this study was to identify risk factors for post-operative bleeding after gastric ESD and to evaluate the relationship between the use of antithrombotic agents and post-operative bleeding. METHODS: From June 2005 to March 2014, 413 patients with 425 gastric neoplasms were treated by ESD. The demographic and clinical parameters associated with post-operative bleeding were investigated. 83 patients receiving antithrombotic agents were separately assessed using various methods of administration during the ESD procedure. Post-operative bleeding that occurred within 5 days of ESD was defined as early post-operative bleeding, whereas subsequent bleeding was defined as delayed bleeding. RESULTS: The overall post-operative bleeding rate was 4.7%. In patients with continued low-dose aspirin (LDA), heparin replacement (HR), or continued LDA along with HR, post-operative bleeding rates were 9.5%, 23.8%, and 25.0%, respectively. On multivariate analysis, a specimen size of ≥40 mm was a risk factor for early post-operative bleeding [odds ratio (OR) 6.08, 95% CI: 1.74–21.27], and HR and chronic kidney disease (CKD) requiring hemodialysis were risk factors for delayed bleeding (OR 12.23, 95% CI: 2.63–56.77 and OR 28.35, 95% CI: 4.67–172.11, respectively). Continued LDA was not a risk factor for post-operative bleeding. CONCLUSIONS: Large specimen size is a risk factor for early post-operative bleeding, and HR and CKD requiring hemodialysis are risk factors for delayed bleeding. Patients with risk factors should be carefully watched, allowing for the timing of post-operative bleeding after ESD. BioMed Central 2014-10-03 /pmc/articles/PMC4287424/ /pubmed/25280756 http://dx.doi.org/10.1186/1471-230X-14-172 Text en © Matsumura et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Matsumura, Tomoaki
Arai, Makoto
Maruoka, Daisuke
Okimoto, Kenichiro
Minemura, Shoko
Ishigami, Hideaki
Saito, Keiko
Nakagawa, Tomoo
Katsuno, Tatsuro
Yokosuka, Osamu
Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
title Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
title_full Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
title_fullStr Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
title_full_unstemmed Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
title_short Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
title_sort risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287424/
https://www.ncbi.nlm.nih.gov/pubmed/25280756
http://dx.doi.org/10.1186/1471-230X-14-172
work_keys_str_mv AT matsumuratomoaki riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents
AT araimakoto riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents
AT maruokadaisuke riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents
AT okimotokenichiro riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents
AT minemurashoko riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents
AT ishigamihideaki riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents
AT saitokeiko riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents
AT nakagawatomoo riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents
AT katsunotatsuro riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents
AT yokosukaosamu riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents